Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03637491
Title A Study of Avelumab, Binimetinib and Talazoparib in Patients With Locally Advanced or Metastatic RAS-mutant Solid Tumors
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Pfizer
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | BEL

Facility Status City State Zip Country Details
Highlands Oncology Group Fayetteville Arkansas 72703 United States Details
Highlands Oncology Group Rogers Arkansas 72758 United States Details
Highlands Oncology Group Springdale Arkansas 72762 United States Details
California Cancer Associates for Research and Excellence, Inc (cCARE) Encinitas California 92024 United States Details
University of Colorado Denver CTO (CTRC) Aurora Colorado 80045 United States Details
University of Colorado Hospital Aurora Colorado 80045 United States Details
Horizon Oncology Research, LLC Lafayette Indiana 47905 United States Details
UPMC Hillman Cancer Center Pittsburgh Pennsylvania 15232 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
University of Utah, Huntsman Cancer Hospital Salt Lake City Utah 84112 United States Details
University of Utah, Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Institut Jules Bordet Brussels 1000 Belgium Details
UZ Gent Gent 9000 Belgium Details
Singapore National Eye Centre Singapore 168751 Singapore Details
Singapore General Hospital Singapore 169608 Singapore Details
SingHealth Investigational Medicine Unit Singapore 169608 Singapore Details
National Heart Centre Singapore Singapore 169609 Singapore Details
National Cancer Centre Singapore Singapore 169610 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field